Hideki Sakai

Prof. Dr. Hideki Sakai

Department of Pharmaceutical Physiology, Faculty of Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan
orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
TFTakuto Fujii
Takuto Fujii
SNShushi Nagamori
Shushi Nagamori
PWPattama Wiriyasermkul
Pattama Wiriyasermkul
SZShizhou Zheng
Shizhou Zheng
AYAsaka Yago
Asaka Yago
Hideki SakaiHideki Sakai
Hideki Sakai
Mutations in the human ATP13A2 (PARK9), a lysosomal ATPase, cause Kufor-Rakeb Syndrome, an early-onset form of Parkinson’s disease (PD). Here, we demonstrate that ATP13A2 functions as a lysosomal H+,K+-ATPase. The K+-dependent ATPase activity and the lysosomal K+-transport activity of ATP13A2 are inhibited by an inhibitor of sarco/endoplasmic reticulum Ca2+-ATPase, thapsigargin, and K+-competitive inhibitors of gastric H+,K+-ATPase, such as vonoprazan and SCH28080. Interestingly, these H+,K+-ATPase inhibitors cause lysosomal alkalinization and α-synuclein accumulation, which are pathological hallmarks of PD. Furthermore, PD-associated mutants of ATP13A2 show abnormal expression and function. Our results suggest that the H+/K+-transporting function of ATP13A2 contributes to acidification and α-synuclein degradation in lysosomes.

11 May 2006 in FEBS Letters
Verified
Journal Article
Closed access
Hideki SakaiHideki Sakai
Hideki Sakai
TSTomoyuki Suzuki
Tomoyuki Suzuki
YTYuji Takahashi
Yuji Takahashi
MUMasashi Ukai
Masashi Ukai
KTKatsunori Tauchi
Katsunori Tauchi
NTNoriaki Takeguchi
Noriaki Takeguchi

14 January 2009 in The Journal of Physiological Sciences
Verified
Journal Article
Open access
PDF file
TWTomoko Watanabe
Tomoko Watanabe
TFTakuto Fujii
Takuto Fujii
TOTakeshi Oya
Takeshi Oya
NHNaoki Horikawa
Naoki Horikawa
YTYoshiaki Tabuchi
Yoshiaki Tabuchi
Hideki SakaiHideki Sakai
Hideki Sakai
Litttle is known about the function of aquaporin (AQP) water channels in human gastric cancer. In the upper or middle part of human stomach, we found that expression level of AQP5 protein in intestinal type of adenocarcinoma was significantly higher than that in accompanying normal mucosa. AQP5 was localized in the apical membrane of the cancer cells. On the other hand, both AQP3 and AQP4 were not up-regulated in the adenocarcinoma. To elucidate the role of AQP5 in cancer cells, AQP5 was exogenously expressed in a cell line of poorly differentiated human gastric adenocarcinoma (MKN45). The AQP5 expression significantly increased the proportion of differentiated cells with a spindle shape, the activity of alkaline phosphatase, a marker for the intestinal epithelial cell type of cancer cells, and the expression level of laminin, an epithelial cell marker. Treatment of the MKN45 cells stably expressing AQP5 with HgCl2, an inhibitor of aquaporins, significantly decreased the proportion of differentiated cells and the activity of alkaline phosphatase. Our results suggest that up-regulation of AQP5 may be involved in differentiation of human gastric cancer cells.

1 January 2009 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
TFTakuto Fujii
Takuto Fujii
YTYuji Takahashi
Yuji Takahashi
AIAkira Ikari
Akira Ikari
MMMagotoshi Morii
Magotoshi Morii
YTYoshiaki Tabuchi
Yoshiaki Tabuchi
Hideki SakaiHideki Sakai
Hideki Sakai
We studied whether K+-Cl- cotransporters (KCCs) are involved in gastric HCl secretion. We found that KCC4 is expressed in the gastric parietal cells more abundantly at the luminal region of the gland than at the basal region. KCC4 was found in the stimulation-associated vesicles (SAV) derived from the apical canalicular membrane but not in the intracellular tubulovesicles, whereas H+,K+-ATPase was expressed in both of them. In contrast, KCC1, KCC2, and KCC3 were not found in either SAV or tubulovesicles. KCC4 coimmunoprecipitated with H+,K+-ATPase in the lysate of SAV. Interestingly the MgATP-dependent uptake of 36Cl- into the SAV was suppressed by either the H+,K+-ATPase inhibitor (SCH28080) or the KCC inhibitor ((R)-(+)-[(2-n-butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-5-yl)oxy]acetic acid). The KCC inhibitor suppressed the H+ uptake into SAV and the H+,K+-ATPase activity of SAV, but the inhibitor had no effects on these activities in the freeze-dried leaky SAV. These results indicate that the K+-Cl- cotransport by KCC4 is tightly coupled with H+/K+ antiport by H+,K+-ATPase, resulting in HCl accumulation in SAV. In the tetracycline-regulated expression system of KCC4 in the HEK293 cells stably expressing gastric H+,K+-ATPase, KCC4 was coimmunoprecipitated with H+,K+-ATPase. The rate of recovery of intracellular pH in the KCC4-expressing cells after acid loading through an ammonium pulse was significantly faster than that in the KCC4-non-expressing cells. Our results suggest that KCC4 and H+,K+-ATPase are the main machineries for basal HCl secretion in the apical canalicular membrane of the resting parietal cell. They also may contribute in part to massive acid secretion in the stimulated state.

1 November 2018 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
TFTakuto Fujii
Takuto Fujii
TSTakahiro Shimizu
Takahiro Shimizu
SYShota Yamamoto
Shota Yamamoto
KFKeisuke Funayama
Keisuke Funayama
KFKyosuke Fujita
Kyosuke Fujita
Hideki SakaiHideki Sakai
Hideki Sakai

1 January 2016
Verified
Book Chapter
Closed access
PDF file
Hideki SakaiHideki Sakai
Hideki Sakai
TFTakuto Fujii
Takuto Fujii
NTNoriaki Takeguchi
Noriaki Takeguchi